Morphine sensitivity of spinal neurons in the chronic constriction injury neuropathic rat pain model

Neuroscience Letters

Volumn 562, Issue , 2014, Pages 97-101

  Hirsch, Silke J ^a   Dickenson, Anthony H ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic constriction injury; In vivo electrophysiology; Morphine; Neuropathy; Pain; Spinal cord

Indexed keywords

CHRONIC CONSTRICTION INJURY; IN VIVO ELECTROPHYSIOLOGY; MORPHINE; NEUROPATHY; PAIN; SPINAL CORD;

ANALGESICS, OPIOID; ANIMALS; CHRONIC DISEASE; CONSTRICTION; DISEASE MODELS, ANIMAL; MALE; MORPHINE; NEURALGIA; NEURONS; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR; SCIATIC NERVE;

EID: 84894253267     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.10.007     Document Type: Article

References (34)

1. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
2. Dworkin R.H., O'Connor A.B., Audette J., Baron R., Gourlay G.K., Haanpaa M.L., Kent J.L., Krane E.J., LeBel A.A., Levy R.M., Mackey S.C., Mayer J., Miaskowski C., Raja S.N., Rice A.S., Schmader K.E., Stacey B., Stanos S., Treede R.D., Turk D.C., Walco G.A., Wells C.D. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin. Proc. 2010, 85:S3-S14.
3. Chaparro L.E., Wiffen P.J., Moore R.A., Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst. Rev. 2012, 7:CD008943.
4. Romano C.L., Romano D., Lacerenza M. Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review. Pain Res. Treat. 2012, 2012:154781.
5. Backonja M.-M. Opioids, clinical opioid tolerance. Encyclopedia of Pain 2007, 1589-1591. Springer, Berlin. R.R. Schmidt, W.D. Willis (Eds.).
6. Bannister K., Dickenson A.H. Opioid hyperalgesia. Curr. Opin. Support. Palliat. Care 2010, 4:1-5.
7. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan T.P., Hruby V.J., Porreca F. Antinociceptive and nociceptive actions of opioids. J. Neurobiol. 2004, 61:126-148.
8. Paster Z., Morris C.M. Treatment of the localized pain of postherpetic neuralgia. Postgrad. Med. 2010, 122:91-107.
9. Leppert W. Pain management in patients with cancer: focus on opioid analgesics. Curr. Pain Headache Rep. 2011, 15:271-279.
10. Papaleontiou M., Henderson C.R., Turner B.J., Moore A.A., Olkhovskaya Y., Amanfo L., Reid M.C. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J. Am. Geriatr. Soc. 2010, 58:1353-1369.
11. Teasell R.W., Mehta S., Aubut J.A., Foulon B., Wolfe D.L., Hsieh J.T., Townson A.F., Short C. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch. Phys. Med. Rehabil. 2010, 91:816-831.
12. Varrassi G., Muller-Schwefe G., Pergolizzi J., Oronska A., Morlion B., Mavrocordatos P., Margarit C., Mangas C., Jaksch W., Huygen F., Collett B., Berti M., Aldington D., Ahlbeck K. Pharmacological treatment of chronic pain - the need for CHANGE. Curr. Med. Res. Opin. 2010, 26:1231-1245.
13. Bennett G.J., Chung J.M., Honore M., Seltzer Z. Models of neuropathic pain in the rat. Curr. Protoc. Neurosci. Chapter 9, Unit 2003.
14. Kim K.J., Yoon Y.W., Chung J.M. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 1997, 113:200-206.
15. Christoph T., Kogel B., Strassburger W., Schug S.A. Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models. Drugs R. D. 2007, 8:51-57.
16. Joshi S.K., Hernandez G., Mikusa J.P., Zhu C.Z., Zhong C., Salyers A., Wismer C.T., Chandran P., Decker M.W., Honore P. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. Neuroscience 2006, 143:587-596.
17. Hama A.T., Borsook D. Behavioral and pharmacological characterization of a distal peripheral nerve injury in the rat. Pharmacol. Biochem. Behav. 2005, 81:170-181.
18. Pedersen L.H., Blackburn-Munro G. Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl) 2006, 185:208-217.
19. Tanimoto-Mori S., Nakazato-Imasato E., Toide K., Kita Y. Pharmacologic investigation of the mechanism underlying cold allodynia using a new cold plate procedure in rats with chronic constriction injuries. Behav. Pharmacol. 2008, 19:85-90.
20. Nakazato-Imasato E., Kurebayashi Y. Pharmacological characteristics of the hind paw weight bearing difference induced by chronic constriction injury of the sciatic nerve in rats. Life Sci. 2009, 84:622-626.
21. Suzuki R., Dickenson A.H. Nerve injury-induced changes in opioid modulation of wide dynamic range dorsal column nuclei neurones. Neuroscience 2002, 111:215-228.
22. Suzuki R., Porreca F., Dickenson A.H. Evidence for spinal dorsal horn hyperexcitability in rats following sustained morphine exposure. Neurosci. Lett. 2006, 407:156-161.
23. Suzuki R., Dickenson A.H. Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp. Neurol. 2006, 198:72-80.
24. Saghaei E., Moini Z.T., Sabetkasaei M., Naseri K. Enhancement of antinociception by co-administrations of nefopam, morphine, and nimesulide in a rat model of neuropathic pain. Korean J. Pain 2012, 25:7-15.
25. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
26. Przewlocki R., Przewlocka B. Opioids in neuropathic pain. Curr. Pharm. Des. 2005, 11:3013-3025.
27. Stevens C.W., Kajander K.C., Bennett G.J., Seybold V.S. Bilateral and differential changes in spinal mu, delta and kappa opioid binding in rats with a painful, unilateral neuropathy. Pain 1991, 46:315-326.
28. Kohno T., Ji R.R., Ito N., Allchorne A.J., Befort K., Karchewski L.A., Woolf C.J. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 2005, 117:77-87.
29. Suzuki R., Chapman V., Dickenson A.H. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain. Pain 1999, 80:215-228.
30. Roeska K., Doods H., Arndt K., Treede R.D., Ceci A. Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain 2008, 139:349-357.
31. De V.J., Kuhl E., Franken-Kunkel P., Eckel G. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur. J. Pharmacol. 2004, 491:137-148.
32. Catheline G., Le G.S., Besson J.M. Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study. Pain 2001, 92:389-398.
33. Urch C.E., Donovan-Rodriguez T., Gordon-Williams R., Bee L.A., Dickenson A.H. Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology. J. Pain 2005, 6:837-845.
34. Baron R., Forster M., Binder A. Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol. 2012, 11:999-1005.